PRECISION BIOSCIENCES INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Precision Biosciences Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • Precision Biosciences Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $32.7M.
  • Precision Biosciences Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $17M.
  • Precision Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$61.3M, a 45.1% increase from 2022.
  • Precision Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$112M, a 265% decline from 2021.
  • Precision Biosciences Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$30.6M, a 71.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $17M $32.7M +$44.6M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$27.7M $8.59M +$33.6M Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-01
Q4 2023 -$61.3M -$16.3M +$12.2M +42.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$73.5M -$8.08M +$15.9M +66.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$89.4M -$11.9M +$19.1M +61.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$109M -$25.1M +$3.11M +11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-01
Q4 2022 -$112M -$28.5M -$6.2M -27.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$105M -$23.9M -$12.7M -112% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$92.8M -$31M -$52.7M -243% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$40.1M -$28.2M -$9.48M -50.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$30.6M -$22.3M +$1.16M +4.96% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$31.8M -$11.3M +$14.7M +56.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$46.5M $21.7M +$54.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$101M -$18.7M +$8.15M +30.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$109M -$23.5M -$2.54M -12.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$106M -$26M -$5.27M -25.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$101M -$32.7M -$13.3M -68.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$87.9M -$26.8M +$4.95M +15.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
Q4 2019 -$92.9M -$20.9M -$5.47M -35.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$87.4M -$20.7M -$11M -113% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$76.4M -$19.4M -$7.61M -64.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$68.8M -$31.8M -$22.8M -253% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$46M -$15.4M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$9.76M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$11.8M Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 -$9.01M Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.